Acción 600998 JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Jointown Pharmaceutical Group Co., Ltd

Acciones

600998

CNE100000W45

Precio de cierre Shanghai S.E.
Otros sitios de cotización
 00:00:00 28/06/2024 		Varia. Cinco días. Varia. 1 de enero.
4,88 CNY -1,41 % Gráfico intradía de Jointown Pharmaceutical Group Co., Ltd -3,56 % -10,20 %
18/06 Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) anuncia una recompra de acciones por valor de 300 millones de CNY. CI
17/06 Jointown Pharmaceutical Group Co., Ltd autoriza un Plan de Recompra. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 300 million worth of its shares.
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
Jointown Pharma's Q1 Profit, Revenue Fall 4%
Jointown Pharmaceutical Group's 2023 Profit Jumps 4%
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 600998
  4. Noticias Jointown Pharmaceutical Group Co., Ltd
  5. Otros idiomas